Valuation Abbott Laboratories Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 15:12:01 28/08/2026 BST			5-day change	1st Jan Change
95.99 ^EUR	-1.65%		-1.83%	-9.52%

08-27	Abbott Laboratories Insider Sold Shares Worth $46,204,798, According to a Recent SEC Filing	MT
08-27	Abbott Laboratories' Stroke Treatment Device Receives CE Mark	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	241,365	191,427	191,088	196,184	217,859	193,093	-	-
Change	-	-20.69%	-0.18%	2.67%	11.05%	-11.37%	-	-
Enterprise Value (EV) ¹	249,166	198,318	198,871	202,693	222,266	217,032	214,051	210,360
Change	-	-20.41%	0.28%	1.92%	9.66%	-2.35%	-1.37%	-1.72%
P/E	35.7x	28.1x	33.8x	14.8x	33.7x	32x	24.7x	22x
PBR	6.93x	5.2x	4.94x	4.11x	4.18x	4.03x	3.86x	3.66x
PEG	-	-36.9x	-2x	0x	-0.7x	-5.09x	0.8x	1.8x
Capitalization / Revenue	5.6x	4.39x	4.76x	4.68x	4.91x	3.84x	3.53x	3.31x
EV / Revenue	5.78x	4.54x	4.96x	4.83x	5.01x	4.31x	3.92x	3.6x
EV / EBITDA	19.4x	15.9x	19.5x	19.1x	18.9x	16.6x	14.7x	13.1x
EV / EBIT	22x	17.7x	22.3x	21.8x	21.6x	18.5x	16.4x	14.7x
EV / FCF	28.8x	25.4x	39.3x	31.9x	30.1x	27.4x	22.9x	20.6x
FCF Yield	3.47%	3.94%	2.54%	3.13%	3.33%	3.65%	4.37%	4.85%
Dividend per Share ²	1.82	1.92	2.08	2.24	2.4	2.571	2.741	2.896
Rate of return	1.29%	1.75%	1.89%	1.98%	1.92%	2.3%	2.46%	2.6%
EPS ²	3.94	3.91	3.26	7.64	3.72	3.486	4.524	5.074
Distribution rate	46.2%	49.1%	63.8%	29.3%	64.5%	73.7%	60.6%	57.1%
Net sales ¹	43,075	43,653	40,109	41,950	44,328	50,302	54,646	58,409
EBITDA ¹	12,815	12,485	10,188	10,635	11,735	13,090	14,598	16,020
EBIT ¹	11,324	11,231	8,911	9,295	10,301	11,719	13,021	14,313
Net income ¹	7,071	6,933	5,723	13,402	6,524	6,232	7,924	8,850
Net Debt ¹	7,801	6,891	7,783	6,509	4,407	23,939	20,957	17,267
Reference price ²	140.74	109.79	110.07	113.11	125.29	111.59	111.59	111.59
Nbr of stocks (in thousands)	1,714,968	1,743,574	1,736,059	1,734,455	1,738,834	1,730,383	-	-
Announcement Date	26/01/22	25/01/23	24/01/24	22/01/25	22/01/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBOTT LABORATORIES	32.01x	4.31x	16.58x	2.3%	193B
MEDTRONIC PLC	20.26x	3.51x	12.4x	3.31%	115B
CENCORA, INC.	17.59x	0.2x	12.85x	0.74%	61.3B
HOYA CORPORATION	29.82x	7.4x	18.9x	1.34%	51.37B
BECTON, DICKINSON AND COMPANY	36.25x	3.48x	11.93x	2.09%	51.24B
DEXCOM, INC.	35.79x	6.3x	19.77x	-.--%	33.69B
MEDLINE INC.	45.48x	1.29x	11.81x	0.17%	30.4B
WEST PHARMACEUTICAL SERVICES, INC.	40.36x	7.07x	25.37x	0.26%	24.36B
TERUMO CORPORATION	19.77x	3.05x	11.13x	1.45%	23.7B
Average	30.81x	4.07x	15.64x	1.3%	64.92B
Weighted average by Cap.	29.13x	3.94x	15.24x	1.87%